175 related articles for article (PubMed ID: 2566649)
1. Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia.
Deakin JF; Slater P; Simpson MD; Gilchrist AC; Skan WJ; Royston MC; Reynolds GP; Cross AJ
J Neurochem; 1989 Jun; 52(6):1781-6. PubMed ID: 2566649
[TBL] [Abstract][Full Text] [Related]
2. Comparison of glutamate and gamma-aminobutyric acid uptake binding sites in frontal and temporal lobes in schizophrenia.
Simpson MD; Slater P; Deakin JF
Biol Psychiatry; 1998 Sep; 44(6):423-7. PubMed ID: 9777172
[TBL] [Abstract][Full Text] [Related]
3. Familial and developmental abnormalities of front lobe function and neurochemistry in schizophrenia.
Deakin FW; Simpson MD; Slater P; Hellewell JS
J Psychopharmacol; 1997; 11(2):133-42. PubMed ID: 9254279
[TBL] [Abstract][Full Text] [Related]
4. Deficits of [3H]D-aspartate binding to glutamate uptake sites in striatal and accumbens tissue in patients with schizophrenia.
Aparicio-Legarza MI; Cutts AJ; Davis B; Reynolds GP
Neurosci Lett; 1997 Aug; 232(1):13-6. PubMed ID: 9292880
[TBL] [Abstract][Full Text] [Related]
5. Glutamate receptors in the postmortem striatum of schizophrenic, suicide, and control brains.
Noga JT; Hyde TM; Herman MM; Spurney CF; Bigelow LB; Weinberger DR; Kleinman JE
Synapse; 1997 Nov; 27(3):168-76. PubMed ID: 9329152
[TBL] [Abstract][Full Text] [Related]
6. Reduced GABA uptake sites in the temporal lobe in schizophrenia.
Simpson MD; Slater P; Deakin JF; Royston MC; Skan WJ
Neurosci Lett; 1989 Dec; 107(1-3):211-5. PubMed ID: 2616032
[TBL] [Abstract][Full Text] [Related]
7. Differential alterations of cortical glutamatergic binding sites in senile dementia of the Alzheimer type.
Chalmers DT; Dewar D; Graham DI; Brooks DN; McCulloch J
Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1352-6. PubMed ID: 2154742
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of schizophrenia: Part II. Temporo-frontal two-step hypothesis.
Kurachi M
Psychiatry Clin Neurosci; 2003 Feb; 57(1):9-15. PubMed ID: 12519449
[TBL] [Abstract][Full Text] [Related]
9. Abnormal excitatory neurotransmitter metabolism in schizophrenic brains.
Tsai G; Passani LA; Slusher BS; Carter R; Baer L; Kleinman JE; Coyle JT
Arch Gen Psychiatry; 1995 Oct; 52(10):829-36. PubMed ID: 7575102
[TBL] [Abstract][Full Text] [Related]
10. A two-process theory of schizophrenia: evidence from studies in post-mortem brain.
Deakin JF; Simpson MD
J Psychiatr Res; 1997; 31(2):277-95. PubMed ID: 9278190
[TBL] [Abstract][Full Text] [Related]
11. An increase in [3H]SCH23390 binding in the cerebral cortex of postmortem brains of chronic schizophrenics.
Domyo T; Kurumaji A; Toru M
J Neural Transm (Vienna); 2001; 108(12):1475-84. PubMed ID: 11810409
[TBL] [Abstract][Full Text] [Related]
12. Reduced high-affinity glutamate uptake sites in the brains of patients with Huntington's disease.
Cross AJ; Slater P; Reynolds GP
Neurosci Lett; 1986 Jun; 67(2):198-202. PubMed ID: 2873534
[TBL] [Abstract][Full Text] [Related]
13. Deficient NMDA-mediated glutamate release from synaptosomes of schizophrenics.
Sherman AD; Hegwood TS; Baruah S; Waziri R
Biol Psychiatry; 1991 Dec; 30(12):1191-8. PubMed ID: 1686412
[TBL] [Abstract][Full Text] [Related]
14. Presynaptic and postsynaptic glutamatergic function in Alzheimer's disease.
Cowburn R; Hardy J; Roberts P; Briggs R
Neurosci Lett; 1988 Mar; 86(1):109-13. PubMed ID: 2896322
[TBL] [Abstract][Full Text] [Related]
15. Glutamate stimulates dopamine release from cortical and limbic rat brain in vitro.
Jones CA; Zempléni E; Davis B; Reynolds GP
Eur J Pharmacol; 1993 Sep; 242(2):183-7. PubMed ID: 7902812
[TBL] [Abstract][Full Text] [Related]
16. A postmortem study of frontal cortical dopamine D1 receptors in schizophrenics, psychiatric controls, and normal controls.
Knable MB; Hyde TM; Murray AM; Herman MM; Kleinman JE
Biol Psychiatry; 1996 Dec; 40(12):1191-9. PubMed ID: 8959283
[TBL] [Abstract][Full Text] [Related]
17. Reduced [3H]flunitrazepam binding in cingulate cortex and hippocampus of postmortem schizophrenic brains: is selective loss of glutamatergic neurons associated with major psychoses?
Squires RF; Lajtha A; Saederup E; Palkovits M
Neurochem Res; 1993 Feb; 18(2):219-23. PubMed ID: 8097289
[TBL] [Abstract][Full Text] [Related]
18. Cortical glutamatergic markers in schizophrenia.
Scarr E; Beneyto M; Meador-Woodruff JH; Dean B
Neuropsychopharmacology; 2005 Aug; 30(8):1521-31. PubMed ID: 15886719
[TBL] [Abstract][Full Text] [Related]
19. N-acetylaspartate and N-Acetylaspartylglutamate deficits in superior temporal cortex in schizophrenia and bipolar disorder: a postmortem study.
Nudmamud S; Reynolds LM; Reynolds GP
Biol Psychiatry; 2003 Jun; 53(12):1138-41. PubMed ID: 12814865
[TBL] [Abstract][Full Text] [Related]
20. Expression of NMDAR1, GluR1, GluR7, and KA1 glutamate receptor mRNAs is decreased in frontal cortex of "neuroleptic-free" schizophrenics: evidence on reversible up-regulation by typical neuroleptics.
Sokolov BP
J Neurochem; 1998 Dec; 71(6):2454-64. PubMed ID: 9832144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
